The transmembrane domain neuregulin 1 mutant mouse - A valuable tool for schizophrenia research?

被引:0
|
作者
Karl, T.
Duffy, L.
Dean, B.
Pavey, G.
Tan, Y. Y.
机构
关键词
D O I
暂无
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
引用
收藏
页码:299 / 299
页数:1
相关论文
共 50 条
  • [21] THE RELEVANCE OF NEUREGULIN 1 MOUSE MODELS FOR SCHIZOPHRENIA RESEARCH AND HOW CANNABINOIDS IMPACT ON ONE PARTICULAR MODEL
    Karl, Tim
    Chesworth, Rose M.
    Boucher, Aurelie A.
    Huang, Xu-Feng
    Long, Leonora E.
    Arnold, Jonathon C.
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2010, 44 : A14 - A14
  • [22] The effects of preventative cannabidiol in a male neuregulin 1 mouse model of schizophrenia
    Visini, Gabriela
    Brown, Samara
    Weston-Green, Katrina
    Shannon Weickert, Cynthia
    Chesworth, Rose
    Karl, Tim
    [J]. FRONTIERS IN CELLULAR NEUROSCIENCE, 2022, 16
  • [24] CANNABINOIDS: ENVIRONMENTAL RISK FACTORS FOR A NEUREGULIN 1 MOUSE MODEL FOR SCHIZOPHRENIA?
    Karl, Tim
    Chesworth, Rose
    Arnold, Jonathon
    Long, Leonora
    [J]. SCHIZOPHRENIA RESEARCH, 2010, 117 (2-3) : 390 - 391
  • [25] A follow-up study: acute behavioural effects of Δ9-THC in female heterozygous Neuregulin 1 transmembrane domain mutant mice
    Leonora E. Long
    Rose Chesworth
    Jonathon C. Arnold
    Tim Karl
    [J]. Psychopharmacology, 2010, 211 : 277 - 289
  • [26] A follow-up study: acute behavioural effects of Δ9-THC in female heterozygous Neuregulin 1 transmembrane domain mutant mice
    Long, Leonora E.
    Chesworth, Rose
    Arnold, Jonathon C.
    Karl, Tim
    [J]. PSYCHOPHARMACOLOGY, 2010, 211 (03) : 277 - 289
  • [27] GENETIC EXPRESSION FOLLOWING NEUREGULIN 1 β DEFICIENCY IN A MOUSE MODEL OF SCHIZOPHRENIA BIOLOGY
    Pulliam, John V. K.
    Ford, G.
    Ford, B.
    Xu, Z.
    Tewolde, T.
    [J]. SCHIZOPHRENIA BULLETIN, 2011, 37 : 75 - 75
  • [28] CANNABIDIOL AS A POTENTIAL PREVENTATIVE TREATMENT IN A NEUREGULIN-1 MOUSE MODEL OF SCHIZOPHRENIA
    Visini, Gabriela
    Chesworth, Rose
    Karl, Tim
    [J]. SCHIZOPHRENIA BULLETIN, 2020, 46 : S298 - S299
  • [29] A NEUREGULIN 1 TRANSMEMBRANE DOMAIN MUTATION CAUSES IMBALANCED GLUTAMATERGIC AND DOPAMINERGIC RECEPTOR EXPRESSION IN MICE
    Newell, K. A.
    Karl, T.
    Huang, X. -F.
    [J]. NEUROSCIENCE, 2013, 248 : 670 - 680
  • [30] Evaluating the Validity of a Novel Transgenic Mouse Model for Neuregulin 1 Type III for Schizophrenia
    Karl, Tim
    [J]. NEUROPSYCHOPHARMACOLOGY, 2015, 40 : S64 - S64